[2P-1395] Functional modification of proteins by incorporation of selenocysteines using cell-fee protein synthesis

〇Eiko Seki¹, Tatsuo Yanagisawa¹, Shigeyuki Yokoyama¹ (1.RIKEN Struct. Biol. Lab)

ConBio2017

[2P-1396] Development of recombinant small antibodies for cell-specific delivery of siRNA

〇Daisuke Mura¹, Takamitsu Hattori¹, Teppei Niide¹, Hikaru Nakazawa¹, Mitsuo Umetsu¹ (1.Dept. of Biom. Eng., Grad. Sch. of Eng., Univ. of Tohoku)

ConBio2017

[2P-1397] Isolation of alpaca VHH mAbs specific for tumor antigens for applications of CAR-T cell immunotherapy

〇Kana Kawazuma¹, Maiko Yoshida², Narutoshi Tsukahara³, Akikazu Murakami², Hidehiro Kishimoto² (1.Sch. of Med., Univ. of the Ryukyus, 2.Grad. Sch. of Med., Univ. of the Ryukyus, 3.Innovex Science Co., Ltd.)

ConBio2017

[2P-1398] Selection of alpaca mAbs specifictor PD-L1/L2 for the novel immunotherapy with antagonistic decoy receptor expressed T cells

〇Yuna Odo¹, Maiko Yoshida², Narutoshi Tukahara³, Akikazu Murakami², Hidehiro Kishimoto² (1.Sch. of Med., Univ. of the Ryukyus, 2.Grad. Sch. of Med., Univ. of the Ryukyus, 3.Innovex Science Co. Ltd)

ConBio2017

[2P-1399] Inhibition of nonspecific interaction become sulerythrin mutants for inhibiting a branching of an artificial protein fiber

〇Tomohiro Uchiyama¹, Sota Yagi¹, Akihiko Yamagishi¹ (1.Dept.of Life Sci., Grad. Sch. of Life Sci., Tokyo Univ of Pharm and Life Sci)

ConBio2017

[2P-1400] Development of purification method of serum AGEs modified protein by use of single-chain Fv antibody fusion molecule

Natsuki Fukuda¹, Soichiro Yamauchi¹, Tsubasa Hayano², Takashi Sato¹, Takeshi Masuda³, Masataka Horiuchi⁴, Yoshihiro Kobashigawa¹, Sumio Ohtsuki³, 〇Hiroshi Morioka¹ (1.Dept. of Anal. Biophys. Chem., Grad. Sch. of Pharm. Sci., Kumamoto Univ., 2.Dept. of Anal. Biophys. Chem., Sch. of Pharm., Kumamoto Univ., 3.Dept. of Pharm. Microbiol., Grad. Sch. of Pharm. Sci., Kumamoto Univ., 4.Fac. of Pharm. Sci., Health Sci. Univ. of Hokkaido)

ConBio2017

[2P-1401] Artificial lectin supramolecular complexes created by protein nanobuilding block strategy

〇Shin Irumagawa¹, Hiroaki Tateno², Jun Hirabayashi², Ryoichi Arai^1,3 (1.Dept. of Appl. Biol., Fac. of Text. Sci. & Tech., Shinshu Univ., 2.Biotech. Res. Inst. for Drug Discov., AIST, 3.CFMD, Shinshu Univ.)

ConBio2017

[2P-1402] Molecular and biochemical analysis of stereospecific monoclonal antibody

〇Keisuke Ichikawa¹, Chiho Miyamae¹, Yushi Isozaki¹, Kanta Tsumoto¹, Masahiro Tomita¹ (1.Mol. Bioeng. Lab., Grad. Sch. Eng., Mie Univ.)

ConBio2017

[2P-1403] Time-lapse imaging of Tau repeat peptides aggregation using quantum dot nanoprobes.

〇Yurika Hashi^1,2, Reina Tainaka², Koji Uwai², Kiyotaka Tokuraku² (1.Gen. Dept. of Aesthetics, Yamano Col., 2.Grad. Sch. Appl, Sci., Muroran Inst.)

ConBio2017

[2P-1404] A trimeric structural fusion of an antagonistic TNF-α mutant enhances molecular stability

〇Masaki Inoue^1,2, Daisuke Ando^2,3, Haruhiko Kamada^2,3,4, Mayumi Niiyama², Yasuo Tsutsumi^3,4, Shin-ichi Tsunoda^1,2,4 (1.Kobe Gakuin Univ., 2.NIBIOHN, 3.Grad. Sch. Pharm. Sci., Osaka Univ., 4.MEIC, Osaka Univ.)

ConBio2017